CorrelaGenes: a new tool for the interpretation of the human transcriptome by Paolo Cremaschi et al.
SOFTWARE Open Access
CorrelaGenes: a new tool for the interpretation
of the human transcriptome
Paolo Cremaschi1, Sergio Rovida2, Lucia Sacchi3, Antonella Lisa1, Francesca Calvi2, Alessandra Montecucco1,
Giuseppe Biamonti1, Silvia Bione1*, Gianni Sacchi2
From Integrated Bio-Search: 12th International Workshop on Network Tools and Applications in Biology
(NETTAB 2012)
Como, Italy. 14-16 November 2012
Abstract
Background: The amount of gene expression data available in public repositories has grown exponentially in the
last years, now requiring new data mining tools to transform them in information easily accessible to biologists.
Results: By exploiting expression data publicly available in the Gene Expression Omnibus (GEO) database, we
developed a new bioinformatics tool aimed at the identification of genes whose expression appeared simultaneously
altered in different experimental conditions, thus suggesting co-regulation or coordinated action in the same
biological process. To accomplish this task, we used the 978 human GEO Curated DataSets and we manually
performed the selection of 2,109 pair-wise comparisons based on their biological rationale. The lists of differentially
expressed genes, obtained from the selected comparisons, were stored in a PostgreSQL database and used as data
source for the CorrelaGenes tool. Our application uses a customized Association Rule Mining (ARM) algorithm to
identify sets of genes showing expression profiles correlated with a gene of interest. The significance of the
correlation is measured coupling the Lift, a well-known standard ARM index, and the c2 p value. The manually
curated selection of the comparisons and the developed algorithm constitute a new approach in the field of gene
expression profiling studies. Simulation performed on 100 randomly selected target genes allowed us to evaluate the
efficiency of the procedure and to obtain preliminary data demonstrating the consistency of the results.
Conclusions: The preliminary results of the simulation showed how CorrelaGenes could contribute to the
characterization of molecular pathways and biological processes integrating data obtained from other applications
and available in public repositories.
Background
The comprehension of the molecular mechanisms
involved in the physiology of human cells requires the
development of new bioinformatics and biostatistics
tools able to integrate and interpret the huge amount of
data derived from different kinds of genome-wide
approaches. The interpretation of the transcriptional
state of the cell and its alterations in specific experimen-
tal or pathological conditions is today of particular
interest and several technologies have been developed to
identify and quantify the entire set of cellular
transcripts. As a consequence, the amount of gene
expression data available in public repositories has
grown exponentially in the last years, now requiring
new data mining tools to extract biologically relevant
information.
Many databases of genome-wide expression data are
today publicly available. Gene Expression Omnibus (GEO)
developed at NCBI [1] and ArrayExpress developed at EBI
[2] are the two main international repositories where
about 45% of microarray published studies has been
deposited [3]. A standardized system for reporting micro-
array results (Minimum Information About a Microarray
Experiment, MIAME) [4] has been developed in order to
facilitate the sharing of high-throughput data among
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scientists. These improvements made it possible to
develop a variety of added-value databases that process
and analyze expression data in order to answer to specific
biological questions [5]. Different methods have been
exploited to combine data from different sources in meta-
analysis studies to reveal new aspects of biological pro-
cesses even if data heterogeneity represents a challenge.
Many procedures were developed in recent years to over-
come this issue resulting in the availability of different
bioinformatics tools. For example, the Oncomine applica-
tion [6] considers gene expression datasets related to the
tumorigenic transformation and the PubLiME tool [7]
bases its analysis mainly on gene signatures. In COX-
PRESdb [8] a homogeneous set of data was selected from
two human platforms and it was compared to expression
data from different organisms. Each of these solutions
offers a view of the whole set of expression data from a
different perspective. For this reason, despite the availabil-
ity of several databases and analysis tools, new bioinfor-
matics approaches to query the increasing amount of
expression data are still required.
In this context we developed CorrelaGenes, a new
bioinformatics tool exploiting GEO expression data to
provide new insights about the pathways in which a
gene of interest could be involved [9]. CorrelaGenes is
aimed at identifying lists of genes potentially correlated
to a gene of interest. This is accomplished through a
cross-sectional analysis among data from different
microarray studies with the ultimate goal of detecting
those genes showing modulation of their expression in a
significant number of different conditions. The Correla-
Genes tool implements a customized Association Rule
Mining (ARM) algorithm and a set of indexes that allow
the user to dynamically explore his target gene combin-
ing different input parameters.
In this paper we will describe the process of data ela-
boration from the GEO archive to the results output file
that users could obtain through the web interface. We will
also describe the indexes we implemented to achieve a
reliable selection of genes correlated with the input target
and their impact on a simulation on 100 randomly
selected genes. Moreover, we will show preliminary data
about the biological relevance of CorrelaGenes results and
how the possibility to choose the type of gene expression
alterations (i.e. up- or down-regulated or both) will help in
the elucidation of molecular pathways and of their players.
Implementation
CorrelaGenes was conceived to explore the biological role
of a gene of interest selected by the user identifying a set
of genes whose expression appeared altered in the same
experimental or physiological state. The tool exploits GEO
expression data and uses a customized Association Rule
Mining algorithm for a cross-sectional analysis aimed at
identifying those genes showing a coordinated modulation
of their transcriptional profiles in different conditions.
A schematic representation of the CorrelaGenes workflow
is shown in Figure 1.
Figure 1 Schematic representation of the CorrelaGenes
workflow.
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Data pre-processing
The source of the expression data used by the Correla-
Genes tool was built from 978 human GEO Curated Data-
Sets (GDS) downloaded from the GEO archive through
the GEOquery 2.21.9 R/Bioconductor package [10]. The
experimental design related to each GDS was used to
group the intensity values measured for single sample
sharing the same experimental factors (Figure 2A). Groups
containing less than two samples were not suitable
for subsequent analysis thus leading to discard a total of
261 GDS. The resulting groups were used to create a
contrast matrix including all groups versus group compar-
isons (Figure 2B). A manually curated knowledge-based
procedure was applied to select appropriate comparisons:
as automatically generated matrices often include con-
trasts without a clear experimental meaning, a team of
biologists defined a set of rules to extract those compari-
sons showing a strong biological rationale (Figure 2C).
Figure 2 shows the procedure applied to GDS2516 (see
also Additional File 1 for a more detailed description of
the whole procedure). In this example a total of seven
experimental factors were identified and used to create an
all groups versus group contrast matrix of 21 comparisons
among which only five were selected by the experts. This
procedure brought to the selection of 2,109 pairwise com-
parisons in 717 GDS. In 1,876 out of 2,109 comparisons a
Figure 2 Schematic representation of GDS2516 processing. (A) Design of GDS2516 and experimental factor definition (F1 to F7). (B) Contrast
matrix created with all groups versus group comparisons. In light blue are shown the 21 pair-wise comparisons. (C) Comparisons manually
selected by the experts. In dark blue are shown the 5 comparisons selected.
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“control” experimental factor was detectable thus allowing
the definition of the sign of the altered expression measure
(i.e. genes up- or down-regulated).
The calculation of the log fold change (LFC) and p value
for each of the selected comparisons was performed with
the linear regression algorithm implemented in the limma
3.10.3 R package [11]. The adjusted p values were obtained
applying the Bayesian estimator implemented in the same
package. The results of these analyses were used to initia-
lize a PostgreSQL 9.1.3 relational database [12] that was
used as data source for the CorrelaGenes application. The
2,188,704 probes obtained from different datasets were
assigned to 190,155 unique identifiers. An automated pro-
cedure based on the biomaRt 2.10.0 R package [13] was
developed to establish the relationship with NCBI official
gene symbol and resulted in the unambiguous mapping of
35,968 identifiers. The remaining 154,284 identifiers were
treated as spurious entities (i.e. corresponding to genomic
elements no longer considered as transcribed); they cannot
be used as target gene even if they were not discarded
from the database. Despite the very limited number of cor-
responding probes (an average of 3.5 probes for unmapped
identifiers against an average of 45.0 probes for official
gene symbols) it is anyway possible that they would appear
in the output list.
To better characterize the dataset used by Correla-
Genes we analyzed the expression measures of the 35,968
official gene symbols that can be used as target genes.
Defining a threshold of absolute LFC ≥ 1 and adjusted
p value ≤ 0.05, a total of 14,163 genes were never found
over- nor under-expressed. The remaining 21,805
showed modulation of their expression in an average of
19 comparisons. In Figure 3, the histogram of the distri-
bution of the number of genes in relation to the number
of comparisons in which they were found modulated is
shown.
ARM algorithm
In order to discover a set of genes that are frequently dif-
ferentially co-expressed CorrelaGenes implements a custo-
mized version of an Association Rule Mining (ARM)
algorithm. In the ARM formalism, datasets are organized
in the form of transactions. Each transaction contains a
list of elements, called items, whose nature depends on the
application. In our context, each transaction corresponds
to a comparison and includes the list of differentially
expressed genes in that transaction. Such genes are
selected on the basis of LFC and adjusted p value thresh-
olds selected by the user. The application uses the transac-
tions to identify association rules (ARs) of the form IF A
THEN C (A=>C). In our context, these rules can be inter-
preted as: IF Set of Genes 1 is differentially expressed in
an experiment THEN Set of Genes 2 is differentially
expressed as well [14].
The ARM theory is based on the concept of frequent
rule. A rule is frequent when it is verified by a sufficient
amount of transactions in the dataset. In the case of
gene expression experiments, an association is consid-
ered frequent if the involved genes are co-modulated in
a sufficiently high number of comparisons. In the origi-
nal ARM algorithm, the quality of an association is
defined by the support. Support gives an idea of how
frequent is a rule in a specific dataset. Given a dataset
containing N transactions, the support of the rule A=>C
will be calculated as NA, C/N, where NA, C is the num-
ber of transactions verifying the rule (i.e. containing all
the items in A and C). An itemset is defined frequent if
its support exceeds a user-defined support threshold.
In recent years different strategies were proposed to
apply the ARM algorithm to the analysis of microarray
expression data [15,16]. In this paper we use a simplified
version of the ARM algorithm, which is based on two
main points: (i) we look for associations containing only
two genes and (ii) one of the involved genes is con-
strained to be the gene selected by the user (Target
gene). In this way, the algorithm will look only for fre-
quent item sets of cardinality 2 (i.e. 2 genes in the rule)
and only for pairs of items involving the target gene as
one of the members. Indicating with T the target gene
and with X a generic gene in the dataset, we will thus
look for rules of the kind IF T THEN X.
Figure 3 Genes modulation in CorrelaGenes. Histogram of the
number of genes with respect to the number of comparisons in
which they were found modulated.
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To measure the quality of the associations, we herein
introduce the following indexes: co-presence, co-expression
(support), Lift and c2 p value. These definitions are based
on the concept of presence and modulation of a gene. A
gene is defined present in a dataset if at least one of the
probes corresponding to it was measured with an adjusted
p value lower than the threshold fixed by the user. A gene
is defined modulated if it is present in the dataset and its
expression value exceeds the specified LFC threshold. The
notations used in the definitions below are explained in
Table 1.
Co-presence is defined as the percentage of compari-
sons where both T and X are present.
co − pres = NTp,Xp
NTp
The co-pres index represents a technical parameter
used to exclude from the analysis all the genes that
were measured with the target in an insufficient number
of times to allow a reliable estimation of the other ARM
indexes.
Co-expression is defined as the percentage of compar-
isons where both gene T and gene X are differentially
expressed. More formally:
co − expr = NTm,Xm
NTp,Xp
This is the adaptation of the notion of support for tra-
ditional ARM algorithm to our domain. The co-expr
index can be used as a raw estimation of the biological
relevance of the association of the gene X expression
with the target. In our simulations it was insufficient to
discriminate the biologically relevant associations from
the background even if it can be used to further rank
the output gene lists.
In traditional ARM algorithm, Lift is defined as the
ratio between the confidence of a rule and the support
of the consequent of the rule. For the scope of this
paper, we define thus Lift as follow:
Lift = NTp,Xp · NTm,XmNTp,Xm · NTm,Xp
The Lift index was the first main parameter allowing
the selection of the genes biologically related with the
target. From its definition a Lift equal to one represents a
gene randomly associated with the target while higher level
of Lift identifies genes with a significant co-modulation. In
our simulations a Lift threshold of two greatly improved
the biological relevance of the output gene lists.
We perform a c2 test to evaluate the number of times
the target gene and gene X result simultaneously differ-
entially expressed compared to the expected value in the
target population. The c2 p value is used to estimate the
independence between the target and a gene X. Even if
this type of index is rarely used to rank ARs, in our
simulations, it resulted useful to discriminate the biolo-
gically relevant associations from the background.
Using ARM to mine frequently associated genes has
several advantages. First of all the search procedure is very
efficient as it is based on the Apriori principle. Second, it
potentially allows a generalization towards considering any
number of genes in the rule, naturally extending the pre-
sent version of the method to more complex regulation
scenarios.
CorrelaGenes web interface
A web interface was created to provide users with an easy
and efficient access to the tool (Figure 4). Connecting to
the CorrelaGenes web page [17], the user can start the
analysis of the gene of interest by defining three sets of
parameters: (i) the official symbol of the gene of interest
(“Target Gene Symbol”) and the sign of the differential
expression (i.e. +1/-1 to restrict the analysis to the com-
parisons where the target gene appeared over/under
expressed or 0 to consider both); (ii) the LFC (different
values could be chosen for the “Target Gene LFC” and for
“Genes LFC”) and the adjusted p value thresholds for the
definition of differentially expressed genes; (iii) the criteria
to filter the list of related genes based on the ARM indexes
(“% Co-Pres”, “Lift”, “c2 p value”). Flanking each input field
a pop-up window is available to help users in the correct
definition of parameters.
As the CorrelaGenes analyses are performed in batch an
e-mail address is required to send the results back to the
user that will initially receive a notification of the job sub-
mission followed by an email containing the link to the
analysis output. The results are structured as tab-delimited
text files and include an 8-rows header summarising all
the analysis parameters and two additional rows indicating
Table 1 Description of the values used in the calculation of ARM indexes
Value Description
NTp Number of comparisons where the target gene is present
NTp, Xp Number of comparisons where both the target gene and gene X are present
NTm, Xm Number of comparisons where the target gene and the gene X are both modulated
NTm, Xp Number of comparisons where the target gene is modulated and the gene X is present
NTp, Xm Number of comparisons where the target gene is present and the gene X is modulated
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the number of comparisons where the target gene was
found present or modulated. Below the header, a table
reports the list of the related genes found together with
their annotation details (i.e.: gene symbol, gene descrip-
tion, chromosome, cytogenetic band, strand, start position,
end position and Ensembl ID) and all the ARM indexes
calculated during the analysis (see Additional File 2).
CorrelaGenes performances
The performance of the algorithm was evaluated in term
of execution time. A preliminary analysis was performed
with 100 randomly selected genes used as targets and with
the following input values: “Target Sign” = 0, “Target
Gene LFC” = 1, “Genes LFC” = 1, “LFC p value” = 0.05,
“% Co-pres” = 40, “Lift” = 2 and “Chi-Square p value” =
0.05. Averaging on the considered 100 genes, the whole
procedure requires a mean execution time of 190 seconds.
We evaluated the average cost of each phase as percentage
of the total execution time. The profiling of the code
showed that the 50% of the total time is spent initializing
the data, the 44% is spent creating the different gene lists
and the 6% is actually spent generating the ARs.
Results
100 genes simulation
To assess the tool functionality, 100 official gene sym-
bols were randomly extracted and analyzed with Corre-
laGenes. For the purpose of this simulation we extracted
our sample among genes modulated in at least one
comparison (i.e. absolute value of LFC ≥ 1, adjusted
p value ≤ 0.05). We run all the analysis setting the fol-
lowing parameters: “Target Sign” = 0, “Target Gene
LFC” = 1, “Genes LFC” = 1, “LFC p value” = 0.05.
A threshold of “% co-pres” = 40 was applied to limit
the number of false positive results due to genes co-
measured in a small number of comparisons. The out-
put lists obtained included an average of 4,403 genes
(range 262-13,170, median = 3,727). Additional File 3
shows the impact of different thresholds of the co-pres
index on the total number of related genes.
Figure 4 Homepage of the CorrelaGenes web interface.
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Different thresholds of the c2 p value and of the Lift
indexes were evaluated (Figure 5). Increasing by a factor
of 10 the threshold of the c2 p value starting from 0.05
and 0.01 resulted in an almost linear reduction of the
number of related genes (Figure 5A). On the contrary,
even small increases in the Lift index drastically reduced
the number of genes in the output lists (Figure 5B).
Increasing the Lift index from 1 to 4 resulted in halving
the number of related genes while for Lift values greater
than 5 the median number of selected genes is always
below 40. A box-plot showing the combined effect of c2
p value and Lift indexes is presented in Additional File 4.
Biological relevance of the results: analysis of the
PRPF19 gene
To assess the biological relevance of the CorrelaGenes
output gene lists we chose to analyze the list obtained
using PRPF19 as Target gene (see Additional File 5).
PRPF19 is a well-characterized gene whose product
plays a role in the formation of the RNA splicing com-
plex [18] and it is also described to be involved in DNA
repair [19], in the regulation of cell cycle [20] and apop-
tosis [21]. The output lists, obtained using the same
expression thresholds set for the simulation study and
comparing different thresholds of Lift and c2 p value,
were evaluated through the Database for Annotation,
Visualization and Integrated Discovery (DAVID v6.7)
[22] Functional Annotation Clustering using Gene
Ontology (GO) biological process as source of informa-
tion [23]. Applying different cut-offs for the c2 p value
(from 0.05 to 5 × 10-6) we obtained a relatively small
decrease in the total number of extracted genes (from
2,526 to 1,406). The analysis of the nine gene lists
showed the presence of clusters (Figure 6A) related to
RNA splicing, cell cycle, DNA repair processes all with
a DAVID Enrichment Scores (ES) always greater than
10.0. Clusters related to apoptosis showed the same
level of ES even if they strongly decreased at c2 p value
threshold smaller than 5 × 10-4. The analysis performed
with a Lift threshold of 2 generated a list of 1,721 genes
that resulted mainly enriched in clusters related to RNA
splicing (ES = 18.4) whereas other processes showed ES
Figure 5 Impact of the ARM indexes on the number of genes
in the output lists. (A) Box-plot of the number of genes with
respect to different thresholds of c2 p value. (B) Box-plot of the
number of genes with respect to different thresholds of Lift.
Figure 6 Analysis of the PRPF19 gene lists. Trend of the DAVID
Enrichment Scores (ES) with respect to different thresholds of c2 p
value with (A) % co-pres = 40 and (B) % co-pres = 40 and Lift = 2
(the GO terms list with related Benjamini p value is available in
Additional Files 7).
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between 4.0 and 6.0. The analysis performed with a Lift
threshold of 3 resulted in a gene list containing only
321 genes with lesser significant DAVID annotations
(see Additional File 6). We repeated the c2 p value ana-
lysis with a threshold of Lift = 2 obtaining lists including
1,720 to 1,189 genes. The DAVID Functional Annota-
tion Clustering highlighted RNA splicing as the most
enriched cluster with an ES of 18.4 (Figure 6B) while
the other clusters obtained lower enrichment scores:
DNA repair (ES = 6.8), cell cycle (ES = 5.9) and regula-
tion of apoptosis (ES = 4.4).
To further characterize PRPF19 related genes we per-
formed the analysis distinguishing between up- or
down-regulation of the target and of related genes. The
results of this analysis (Figure 7) allowed to identify dif-
ferent expression relationships between the target and
its correlated genes. In particular, the apoptotic process
appeared inversely related to the up- or down-regulation
of PRPF19 while DNA repair and cell cycle appeared
directly related. Finally, the expression level of the
PRPF19 gene seemed to be a limiting factor for the
RNA splicing process as its down-regulation results in a
list of down-regulated genes highly enriched (ES = 15.9)
for this function.
Discussion
In this paper we described the development of a new
bioinformatics tool, CorrelaGenes, which exploits pub-
licly available expression data to extract lists of genes
transcriptionally correlated with a gene of interest.
The transcriptional profiles used by CorrelaGenes
came from 978 human datasets obtained from the GEO
archive that were manually elaborated to select a subset
of 2,109 comparisons with a consistent biological ratio-
nale. This represents an added value of this new tool as
the automated procedures, often employed to analyze
the GEO data, introduce distortions due to the presence
of spurious correlations.
Moreover, due to the increasing number of curated
datasets available at the GEO archive, we planned a quar-
terly update of CorrelaGenes. This process will include the
addition of the new studies along with the manually
curated knowledge-based selection of pairwise compari-
sons thus improving the overall accuracy of the results.
The CorrelaGenes tool was implemented with a custo-
mized ARM algorithm that provides the user with a
variety of indexes through which it is possible to modu-
late the features of the extracted gene list thus exploring
different biological perspectives when considering the
function of the target gene. The possibility of choosing
different levels of gene expression modulations (i.e.
values of LFC) and distinguishing between over- or
under-expression of the target gene (i.e. Target sign)
allowed to focus the analysis on specific aspects of cell
function and regulation. The tuning of the “co-pres” fil-
ter appeared particularly helpful in the reduction of
experimental background as it limits the analysis to a
number of observations suitable to avoid the majority of
false positive results. Moreover, combinations of the Lift
and c2 p value can be used to dissect pathways where a
target gene acts in different cellular conditions thus
helping to untangle its complex functioning. The values
we suggested as default appeared suitable for a general
characterization of a gene of interest. Depending on the
user expectations, more stringent thresholds (i.e. higher
Lift and lower c2 p value) could be used to reduce the
occurrence of false positive results being aware that a
concomitant reduction in informative genes could not
be ruled out.
The availability of large amount of data boosted the
development of new bioinformatics tools allowing to
explore many aspects of gene expression profiles applying
different types of meta-analysis. To create CorrelaGenes
we focused on two aspects that we considered not fully
exploited: the possibility to combine many studies with
no restriction in the platform selection and with no
restrictions in the experimental factors. The first point
guided us to the choice of the ARM algorithm that we
found to be robust handling the high number of missing
Figure 7 Analysis of up- and down-regulation in PRPF19 gene
lists. Trend of the DAVID Enrichment Scores (ES) with respect to
different thresholds of c2 p value with % co-pres = 40 and Lift = 2
distinguishing between up- or down-regulated target and related
genes (the GO terms list with related Benjamini p value is available
in Additional File 7).
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values present in data source. To address the second
point, we included in CorrelaGenes all curated datasets
available in GEO taking in consideration all different
experimental factors used to perturb cell physiology. This
feature might allow CorrelaGenes to explore different
aspects of gene functions and represents the main differ-
ence with respect to other tools as Oncomine and Pub-
liME that focus their analysis on cancer biology.
The gene lists obtained with our tool can be analyzed by
other bioinformatics resources to get insight into the bio-
logical processes or molecular mechanisms where the
genes appeared involved. In this paper we used the DAVID
web tool to annotate the gene list corresponding to the
PRPF19 target gene. As illustrated in the results section,
the obtained list is consistent with the known biological
role of this gene thus providing a reliable source where to
look for new players of the same process or to search for
unknown processes in which the target gene could be
involved.
Conclusions
The CorrelaGenes tool, through a new approach for the
characterization of human genes transcriptional profiles,
could contribute to the comprehension of molecular
pathways regulating cell physiology.
Availability and requirements
• Project name: CorrelaGenes
• Project home page: http://www.igm.cnr.it/cabgen/
• Operating system(s): Platform independent
• Software requirements: Web browser (supported
browser Firefox, Safari, Chrome)
• Other requirements: an e-mail account
• Programming language: Fortran, R 2.14, PHP5.2.6,
TYPO3 4.5.6
• Updates: the tool will be updated quarterly
• Licence: Free to academic, government and non-
profit users for non-commercial use.
Additional material
Additional file 1: Contrast matrix creation and comparisons
selection. The file includes, in PDF format, the detailed description of
the contrast matrix creation process and the curated knowledge-based
procedure workflow.
Additional file 2: Description of the output file header.
Additional file 3: Impact of the % co-pres index on the number of
genes in the output lists.
Additional file 4: Impact of the Lift and c2 p value indexes on the
number of correlated genes.
Additional file 5: PRPF19 Output gene list. The file include the output
gene list, in a tab-delimited text format, obtained by the analysis of the
PRPF19 gene.
Additional file 6: Analysis of the PRPF19 gene lists. Trend of the
DAVID Enrichment Scores (ES) respect to different Lift thresholds.
Additional file 7: DAVID Functional Annotation Chart related to the
output lists used in Figures 6, 7.
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